BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10660579)

  • 1. HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution.
    Collette Y; Arold S; Picard C; Janvier K; Benichou S; Benarous R; Olive D; Dumas C
    J Biol Chem; 2000 Feb; 275(6):4171-6. PubMed ID: 10660579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.
    Greenway AL; Dutartre H; Allen K; McPhee DA; Olive D; Collette Y
    J Virol; 1999 Jul; 73(7):6152-8. PubMed ID: 10364375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase.
    Choi HJ; Smithgall TE
    J Mol Biol; 2004 Nov; 343(5):1255-68. PubMed ID: 15491611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity of simian immunodeficiency virus strain mac Nef for high-affinity Src homology 3 (SH3) binding revealed by ligand-tailored SH3 domains.
    Hiipakka M; Saksela K
    J Gen Virol; 2002 Dec; 83(Pt 12):3147-3152. PubMed ID: 12466492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.
    Lee CH; Leung B; Lemmon MA; Zheng J; Cowburn D; Kuriyan J; Saksela K
    EMBO J; 1995 Oct; 14(20):5006-15. PubMed ID: 7588629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
    Saksela K; Cheng G; Baltimore D
    EMBO J; 1995 Feb; 14(3):484-91. PubMed ID: 7859737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nef proteins of distinct HIV-1 or -2 isolates differ in their binding properties for HCK: isolation of a novel Nef binding factor with characteristics of an adaptor protein.
    Karn T; Hock B; Holtrich U; Adamski M; Strebhardt K; Rübsamen-Waigmann H
    Virology; 1998 Jun; 246(1):45-52. PubMed ID: 9656992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
    Arold S; Franken P; Strub MP; Hoh F; Benichou S; Benarous R; Dumas C
    Structure; 1997 Oct; 5(10):1361-72. PubMed ID: 9351809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
    Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
    Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo.
    Briggs SD; Lerner EC; Smithgall TE
    Biochemistry; 2000 Jan; 39(3):489-95. PubMed ID: 10642173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
    Hiipakka M; Poikonen K; Saksela K
    J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1.
    Briggs SD; Sharkey M; Stevenson M; Smithgall TE
    J Biol Chem; 1997 Jul; 272(29):17899-902. PubMed ID: 9218412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity.
    Sawai ET; Baur AS; Peterlin BM; Levy JA; Cheng-Mayer C
    J Biol Chem; 1995 Jun; 270(25):15307-14. PubMed ID: 7797518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.
    Cheng H; Hoxie JP; Parks WP
    Virology; 1999 Nov; 264(1):5-15. PubMed ID: 10544125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2.
    Howe AY; Jung JU; Desrosiers RC
    J Virol; 1998 Dec; 72(12):9827-34. PubMed ID: 9811718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity.
    Greenway A; Azad A; Mills J; McPhee D
    J Virol; 1996 Oct; 70(10):6701-8. PubMed ID: 8794306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4.
    Hua J; Cullen BR
    J Virol; 1997 Sep; 71(9):6742-8. PubMed ID: 9261398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques.
    Khan IH; Sawai ET; Antonio E; Weber CJ; Mandell CP; Montbriand P; Luciw PA
    J Virol; 1998 Jul; 72(7):5820-30. PubMed ID: 9621042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.